What to do for constipation after no bowel movement in one week with Miralax (polyethylene glycol) treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Constipation After One Week Without Bowel Movement Despite Miralax Treatment

For a patient who has not had a bowel movement in one week despite using Miralax (polyethylene glycol), you should increase the Miralax dosage to 1 capful/8 oz water twice daily and add a stimulant laxative such as bisacodyl 10-15 mg daily. 1

Initial Assessment

  • Rule out impaction by performing a digital rectal examination to assess pelvic floor motion during simulated evacuation 1
  • Check for obstruction through physical examination and consider abdominal x-ray if symptoms are severe 1
  • Evaluate for other causes of constipation such as hypercalcemia, hypokalemia, hypothyroidism, diabetes mellitus, or medication side effects 1
  • Review and discontinue any non-essential constipating medications (antacids, anticholinergics, antidepressants, antispasmodics, phenothiazines, haloperidol, antiemetics) 1

Immediate Management

  • Increase polyethylene glycol (Miralax) dosage to 1 capful/8 oz water twice daily 1, 2
  • Add a stimulant laxative such as bisacodyl 10-15 mg daily-TID with a goal of achieving one non-forced bowel movement every 1-2 days 1
  • Ensure adequate fluid intake and encourage physical activity if appropriate 1
  • Consider dietary modifications including increased fiber intake if patient has adequate fluid intake 1

If No Response Within 24-48 Hours

  • Consider administering a glycerine suppository or bisacodyl suppository (one rectally daily-BID) 1
  • Evaluate for fecal impaction; if present, consider manual disimpaction following pre-medication with analgesic ± anxiolytic 1
  • Consider adding other laxative options:
    • Lactulose, 30-60 mL BID-QID 1
    • Sorbitol, 30 mL every 2 hours × 3, then as needed 1
    • Magnesium hydroxide, 30-60 mL daily-BID 1
    • Magnesium citrate, 8 oz daily 1

For Severe or Persistent Constipation

  • Consider a higher dose of polyethylene glycol - studies have shown that doses up to 68g (approximately 4 capfuls) can be effective and safe for severe constipation 2, 3
  • For opioid-induced constipation that doesn't respond to standard laxative therapy, consider methylnaltrexone 0.15 mg/kg subcutaneously every other day (no more than once daily) 1
  • Consider tap water enema until clear if other measures fail 1
  • If gastroparesis is suspected, add a prokinetic agent such as metoclopramide 10-20 mg PO QID 1

Important Considerations

  • Bisacodyl should not be used for longer than one week without medical supervision 4
  • Polyethylene glycol alone may not provide lasting effectiveness for chronic constipation; combination therapy is often needed 5
  • If constipation persists despite appropriate treatment, consider referral for specialized testing such as colonic transit studies or anorectal manometry 1
  • Be aware that diarrhea accompanying constipation may indicate overflow around impaction 1
  • For patients with chronic constipation, newer agents such as lubiprostone or linaclotide may be considered if standard treatments fail 1, 6

Follow-up

  • Reassess the patient within 24-48 hours to determine response to therapy 1
  • If constipation resolves, continue maintenance therapy with the effective regimen for at least several days, then consider tapering 1
  • If symptoms persist despite escalation of therapy, consider specialized gastroenterology consultation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Overnight efficacy of polyethylene glycol laxative.

The American journal of gastroenterology, 2002

Research

Medical management of constipation.

Clinics in colon and rectal surgery, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.